Feb. 5, 2025 — Researchers report that all nine patients in a clinical trial being treated for stage III or IV clear cell renal cell carcinoma (a form of kidney cancer), generated a successful ...

Here the authors analyze data from COVAIL trial participants receiving an mRNA second COVID-19 vaccine boost and show that, while neutralizing antibody titer is correlated with Omicron COVID-19 ...

US biotech Novavax has begun a phase 1 study of its coronavirus vaccine, as the number in clinical development reached double figures. The World Health Organization has been keeping tabs on ...

Scott Burris, director of Temple University’s Center for Public Health Law Research, has tracked public health legislation for years, and watched backlash against COVID-19 vaccines grow to ...

The "excess mortality" associated with the pandemic in calendar years 2021 and 2021 – deaths from COVID-19 itself and lack of access to healthcare for other illnesses – was around 13% higher ...

Reviewers have tested some of the products below and may have received some products from the manufacturers for free. All opinions are the reviewers’ own. These full-spectrum gummies are ...

This page requires JavaScript to be enabled to properly display data shown within components like charts, tables, etc.. Circulation of respiratory viruses is normally ...

COVID-19 is at a low level in the community. Read the latest data from NSW Health. Continue to protect other people. Please stay home if you have any cold or flu symptoms. Wear a mask if you need to ...

“They are becoming vaccine-hesitant.” Pfizer, Moderna and Novavax — the makers ... Pulling emergency use authorization of Covid vaccines for children While the FDA has approved Covid ...

The hepatitis B vaccine is a shot, typically injected into the arm, that protects against hepatitis B in babies, children, and adults. It is an important way to protect yourself and your children from ...

The Trump administration is preparing an executive order that would halt federal funding, at least temporarily, for a risky and controversial kind of research into viruses that makes the pathogens ...

shares of this vaccine maker have returned +3.5%, compared to the Zacks S&P 500 composite's +2.1% change. During this period, the Zacks Medical - Biomedical and Genetics industry, which Novavax ...